Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:53:11 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Q:CMRX - CHIMERIX INC - http://www.chimerix.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CMRX - Q0.20.8831·0.890.30.89-0.0423-4.5135.3982500.94  0.94  0.88881.57  0.8811:32:41Apr 1615 min RT 2¢

Recent Trades - Last 10 of 250
Time ETExPriceChangeVolume
11:32:41Q0.89-0.0423500
11:32:39Q0.89-0.0423100
11:32:39Q0.89-0.042373
11:32:39Q0.89-0.0423100
11:32:39Q0.89-0.0423100
11:32:39Q0.89-0.04236,686
11:32:39Q0.89-0.0423100
11:32:39Q0.89-0.0423200
11:32:39Q0.889-0.0433100
11:32:39Q0.889-0.0433100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-16 16:05U:CMRXNews ReleaseChimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-21 07:00U:CMRXNews ReleaseChimerix Appoints Marc D. Kozin to Board of Directors
2024-02-29 07:00U:CMRXNews ReleaseChimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
2024-02-27 07:00U:CMRXNews ReleaseChimerix to Present at TD Cowen 44th Annual Health Care Conference
2024-02-22 07:00U:CMRXNews ReleaseChimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
2023-12-29 07:00U:CMRXNews ReleaseChimerix Appoints Lisa Decker to Board of Directors
2023-12-04 07:00U:CMRXNews ReleaseChimerix Promotes Michelle LaSpaluto to Chief Financial Officer
2023-11-24 07:00U:CMRXNews ReleaseChimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-11-16 07:00U:CMRXNews ReleaseChimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
2023-11-02 07:00U:CMRXNews ReleaseChimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
2023-10-26 07:00U:CMRXNews ReleaseChimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
2023-09-05 07:00U:CMRXNews ReleaseChimerix to Participate in Upcoming Investor Conferences
2023-08-16 10:05U:CMRXNews ReleaseChimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
2023-08-03 07:00U:CMRXNews ReleaseChimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
2023-07-27 07:00U:CMRXNews ReleaseChimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
2023-06-27 16:05U:CMRXNews ReleaseChimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
2023-05-31 16:01U:CMRXNews ReleaseChimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
2023-05-25 07:00U:CMRXNews ReleaseChimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
2023-05-04 07:00U:CMRXNews ReleaseChimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
2023-04-27 07:00U:CMRXNews ReleaseChimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023